Incheon Airport Korea purchases additional QS-B220s

WILMINGTON, MASS. - Implant Sciences Corporation, a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced that it has shipped a follow-on order for additional QS-B220 desktop explosives trace detectors to Incheon International Airport, the largest airport in South Korea. The order, valued at over $500,000, was procured by Incheon International Airport Corporation, operator of Incheon International Airport. Last year, Incheon installed 12 QS-B220s to replace ETD systems from another manufacturer.

Implant Sciences has received orders over 2,000 systems to international airports worldwide since November, 2014.

"Given our sole focus on trace detection, we have a deeper knowledge of our customers' needs and current security challenges. By being focused and nimble, we are able to respond quickly and implement innovative technology, which is one of our best competitive advantages," stated Dr. Darryl Jones, Implant Sciences' Vice President of Global Sales and Marketing. "We strive to raise the bar for the industry, not only with our technology, but also in responsiveness in service and user experience."

"As security demands increase, customers are looking for products that deliver reliable and efficient security solutions, while also making their lives easier," added Dr. Bill McGann, CEO of Implant Sciences. "Implant Sciences is pleased to have received this follow-on order from Incheon International Airport Corporation to provide our next generation trace detection equipment for checkpoint screening."

sourced:traveldailynews.asia